The bulky N(6) substituent of cabergoline is responsible for agonism of this drug at serotonin 5-HT2a and 5-HT2b receptors and thus a determinant of valvular heart disease - Kekewska, Alexandra; Hübner, Harald; Gmeiner, Peter; Pertz, Heinz H. (Journal of Pharmacology and Experimental Therapeutics, 2011)
UnivIS-Import:2018-09-05:Pub.2011.nat.dchph.lphch.thebul